Teladoc Health, Inc. Information Request Form

Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of Teladoc Health, Inc. (“Teladoc”) (NYSE: TDOC) with Livongo Health, Inc. (“Livongo”) (NASDAQ: LVGO). Under the terms of the merger, each share of Livongo will be exchanged for 0.5920x shares of Teladoc Health plus cash consideration of $11.33 for each Livongo share.

The Teladoc merger investigation concerns whether the Board of Teladoc has harmed stockholders by agreeing to enter into this transaction and whether all material facts have been properly disclosed to stockholders.